Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives
RSC Advances · 2025 · 15 (1) · 231-243
DOI: 10.1039/d4ra06954d ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Jia-Xing Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Henan University of Chinese Medicine Zhengzhou 450046 China hn_xap@163.com 18515912322@163.com hnzz_yuan@hactcm.edu.cn. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Quinoline-based dihydrazone derivative 3b showed multiple anticancer mechanisms. 3b could not only induce apoptosis of MCF-7 cells and bind to DNA , but also act as a CDK2 inhibitor.
Autor:innen und Institutionen
- School of Pharmacy, Henan University of Chinese Medicine Zhengzhou 450046 China hn_xap@163.com 18515912322@163.com hnzz_yuan@hactcm.edu.cn.
- Academy of Chinese Medical Sciences, Henan University of Chinese Medicine Zhengzhou 450046 China.
ORCID-Profile: Juan Yuan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
Zitieren
APA
Lu, J. X., Lan, H. R., Zeng, D., Song, J. Y., Hao, Y. T., Xing, A. P., Shen, A., & Yuan, J. (2025). Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives. RSC Advances, 15(1), 231-243. https://doi.org/10.1039/d4ra06954d
Vancouver
Lu JX, Lan HR, Zeng D, Song JY, Hao YT, Xing AP, et al. Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives. RSC Advances. 2025;15(1):231-243. doi:10.1039/d4ra06954d
BibTeX
@article{Lu2025,
author = {Lu, Jia-Xing and Lan, Hai-Rong and Zeng, Dai and Song, Jun-Ying and Hao, Ya-Ting and Xing, Ai-Ping and Shen, Ao and Yuan, Juan},
title = {Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {1},
pages = {231--243},
doi = {10.1039/d4ra06954d}
}
EUVIMED